Pricing Log in Create free account

Brainstorm Cell Therapeutics Inc. (BCLI) vs Skye Bioscience, Inc. (SKYE)

Brainstorm Cell Therapeutics Inc. and Skye Bioscience, Inc. are both Biotechnology companies. Brainstorm Cell Therapeutics Inc. and Skye Bioscience, Inc. are of similar size ($7.0M and $7.0M). Across the 9 metrics below, Brainstorm Cell Therapeutics Inc. leads on 6 and Skye Bioscience, Inc. on 3.

Valuation

Metric BCLI SKYE Biotechnology median
P/E n/m n/m 8.50
P/S n/m 25.76 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 12.92 9.21
Earnings yield (119.40%) (655.48%) (33.15%)
Free cash flow yield (47.20%) (497.63%) (25.50%)

Profitability

Metric BCLI SKYE Biotechnology median
Gross margin 0.00% 68.04% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 119.20% (233.87%) (56.36%)
Return on assets (627.43%) (159.80%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BCLI SKYE Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 51.95% (93.15%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCLI SKYE Biotechnology median
Debt to equity (0.11) 0.00 0.00
Current ratio 0.03 0.95 4.72
Net debt to EBITDA (0.10) 0.45 0.96

Dividend

Metric BCLI SKYE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BCLI SKYE Biotechnology median
Market cap 6.99m 7.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack